EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 95 filers reported holding EDGEWISE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,886 | -13.0% | 21,097 | +17.7% | 0.00% | – |
| Q2 2023 | $138,880 | -11.8% | 17,920 | -24.1% | 0.00% | – |
| Q1 2023 | $157,392 | +5.8% | 23,597 | +41.8% | 0.00% | – |
| Q4 2022 | $148,735 | +25.0% | 16,637 | +37.9% | 0.00% | – |
| Q3 2022 | $119,000 | +6.2% | 12,064 | -14.2% | 0.00% | – |
| Q2 2022 | $112,000 | -47.7% | 14,055 | -36.1% | 0.00% | – |
| Q1 2022 | $214,000 | -42.8% | 21,996 | -10.2% | 0.00% | – |
| Q4 2021 | $374,000 | +206.6% | 24,494 | +232.3% | 0.00% | – |
| Q3 2021 | $122,000 | -21.8% | 7,370 | +0.3% | 0.00% | – |
| Q2 2021 | $156,000 | – | 7,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $50,494,000 | 11.75% |
| Novo Holdings A/S | 5,587,207 | $181,584,000 | 7.50% |
| Orbimed Advisors | 13,944,680 | $453,202,000 | 4.24% |
| Logos Global Management LP | 1,056,812 | $34,346,000 | 3.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $127,827,000 | 2.69% |
| EcoR1 Capital, LLC | 1,224,175 | $39,786,000 | 1.76% |
| Cormorant Asset Management, LP | 2,340,914 | $74,307,000 | 1.66% |
| Octagon Capital Advisors LP | 125,000 | $4,063,000 | 1.53% |
| RA Capital Management | 2,613,623 | $84,943,000 | 1.28% |
| Soleus Capital Management, L.P. | 100,000 | $3,250,000 | 0.59% |